| Dr Suzanne A Beck, MD | |
|
3502 22nd St, Lubbock, TX 79410-1308 | |
| (806) 799-4192 | |
| Not Available |
| Full Name | Dr Suzanne A Beck |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 38 Years |
| Location | 3502 22nd St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861597973 | NPI | - | NPPES |
| 034074701 | Medicaid | TX | |
| 0082EB | Other | TX | BCBS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | H2237 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Suzanne A Beck Md Pa | 4789659392 | 5 |
News Archive
Researchers at the Colorado School of Public Health have found a possible connection between the intensity of oil and gas exploration in an area and early indicators of cardiovascular disease among nearby residents.
Regular exercise speeds learning and improves blood flow to the brain, according to a new study led by researchers from the University of Pittsburgh School of Medicine that is the first to examine these relationships in a non-human primate model. The findings are available in the journal Neuroscience.
It costs the global economy an estimated US$2 trillion annually and has been dubbed a modern day health epidemic, but new research from the University of South Australia has unearthed a possible cure for obesity – and it is as plain as dirt!
Algeta ASA, a company focused on the development of novel targeted cancer therapeutics, today announced that radium-223 chloride has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant (hormone refractory) prostate cancer in patients with bone metastases.
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
› Verified 3 days ago
| Entity Name | Suzanne A Beck Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174642037 PECOS PAC ID: 4789659392 Enrollment ID: O20040827000624 |
News Archive
Researchers at the Colorado School of Public Health have found a possible connection between the intensity of oil and gas exploration in an area and early indicators of cardiovascular disease among nearby residents.
Regular exercise speeds learning and improves blood flow to the brain, according to a new study led by researchers from the University of Pittsburgh School of Medicine that is the first to examine these relationships in a non-human primate model. The findings are available in the journal Neuroscience.
It costs the global economy an estimated US$2 trillion annually and has been dubbed a modern day health epidemic, but new research from the University of South Australia has unearthed a possible cure for obesity – and it is as plain as dirt!
Algeta ASA, a company focused on the development of novel targeted cancer therapeutics, today announced that radium-223 chloride has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant (hormone refractory) prostate cancer in patients with bone metastases.
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suzanne A Beck, MD 3502 22nd St, Lubbock, TX 79410-1308 Ph: (806) 799-4192 | Dr Suzanne A Beck, MD 3502 22nd St, Lubbock, TX 79410-1308 Ph: (806) 799-4192 |
News Archive
Researchers at the Colorado School of Public Health have found a possible connection between the intensity of oil and gas exploration in an area and early indicators of cardiovascular disease among nearby residents.
Regular exercise speeds learning and improves blood flow to the brain, according to a new study led by researchers from the University of Pittsburgh School of Medicine that is the first to examine these relationships in a non-human primate model. The findings are available in the journal Neuroscience.
It costs the global economy an estimated US$2 trillion annually and has been dubbed a modern day health epidemic, but new research from the University of South Australia has unearthed a possible cure for obesity – and it is as plain as dirt!
Algeta ASA, a company focused on the development of novel targeted cancer therapeutics, today announced that radium-223 chloride has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant (hormone refractory) prostate cancer in patients with bone metastases.
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.
› Verified 3 days ago
Mr. Robert J Mamlok, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 5424 19th Street, Suite #300, Lubbock, TX 79407 Phone: 806-795-4391 Fax: 806-796-1354 | |
Dr. Eileen Talusan-garcia, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 7501 Quaker Ave, Lubbock, TX 79424 Phone: 806-793-7257 Fax: 806-799-1568 | |
Dr. Amanda Lewis, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3502 22nd St, Lubbock, TX 79410 Phone: 806-799-4192 Fax: 806-799-6299 |